Search results
Awakn Life Sciences (CSE: AWKN) (OTCQB: AWKNF) is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use ...
3 days ago · Shares Outstanding 40.377M. Price to Sales Ratio 39.92. 1 Year Return –50.00%. 30 Day Avg Volume 10,444.83. EPS -0.13. About AWAKN Life Sciences Corp. Awakn Life Sciences Corp. operates as a ...
Feb 12, 2024 · Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition ...
Nov 15, 2023 · Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing therapeutics targeting addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting ...
May 7, 2024 · Investor Relations. About Awakn. Awakn Life Sciences is a clinical-stage biotechnology company developing therapeutics to treat addiction, with a near-term focus on Alcohol Use Disorder. We are focused on treating addiction because it is a significant unmet medical need driven by high prevalence rates and high relapse rates.
Jun 23, 2021 · With today’s launch, Awakn has become the fourth psychedelics-focused biotech company to list on the NEO Exchange, along with Mydecine Innovations Group, Cybin Inc., and MindMed, the world’s ...
Jun 9, 2023 · Awakn Life Sciences Corp. is a biotechnology company developing therapeutics targeting addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting 285m people ...
